title: An alternative to PVP for slowing sperm prior to ICSI.
abstract: BACKGROUND
  There is a growing awareness of potential problems in exposing sperm to polyvinylpyrrolidone (PVP) to slow their motility, a procedure commonly used prior to ICSI. The study presented here evaluates an alternative product for slowing sperm motility, which contains hyaluronate, a substance found naturally in the reproductive tract.
  
  
  METHODS
  Computerized sperm motility analysis was used to compare the motilities of sperm exposed to either a PVP-containing product (ICSI-100), or a hyaluronate-containing product (SpermCatch), or control sperm resuspended in a sperm maintenance medium. A subjective assessment was made of the ease with which sperm could be isolated and be drawn into, and expelled from, an injection pipette after having their tails nicked. Sperm exposed to either ICSI-100 or SpermCatch were used for ICSI. Fertilization rate, zygote development, grading, and outcome of transfer were recorded for the two treatment groups.
  
  
  RESULTS
  The hyaluronate-containing product slowed sperm motility sufficiently for the sperm to be captured in an injection pipette, was easy to draw into and expel from the pipette, prevented sperm sticking to plastic or glassware, and did not affect post-injection zygote development. Clinical pregnancy rates were similar for the two groups.
  
  
  CONCLUSIONS
  This product represents an alternative to PVP for slowing sperm motility prior to ICSI.
authors.affiliation: American Hospital, Istanbul, Turkey.
authors.forename: B
authors.initials: B
authors.lastname: Balaban
authors.forename: K
authors.initials: K
authors.lastname: Lundin
authors.forename: J M
authors.initials: JM
authors.lastname: Morrell
authors.forename: H
authors.initials: H
authors.lastname: Tjellström
authors.forename: B
authors.initials: B
authors.lastname: Urman
authors.forename: P V
authors.initials: PV
authors.lastname: Holmes
mesh_terms: D002970:Cleavage Stage, Ovum / Q000187:drug effects; D001330:Electronic Data Processing; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology*; D008297:Male; D011205:Povidone / Q000494:pharmacology; D011247:Pregnancy; D018873:Pregnancy Rate; D020554:Sperm Injections, Intracytoplasmic; D013081:Sperm Motility / Q000187:drug effects*; D020858:Tissue and Organ Harvesting / Q000379:methods*
chemical_list: D006820:Hyaluronic Acid; D011205:Povidone